{"transactions":[{"id":1338589,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Option (right to buy)","published_at":"2024-12-09T21:00:25.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":226000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the 2021 Stock Incentive Plan. The option will become 100% vested and exercisable on December 5, 2026, the two-year anniversary of the grant date."}],"balance_after":226000,"derivative":{"exercise_price":5.05,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":226000},"source":{"system":"sec-edgar","filing":"0001213900-24-106918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390024106918/ownership.xml","form_type":"4"}},{"id":1406320,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock Warrants (right to buy)","published_at":"2024-09-17T00:48:44.000Z","date":"2024-09-12","kind":"purchase","planned":false,"acquired":true,"shares":15380,"price":0.125,"value":1922.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common shares and warrants reported on this Form 4 were purchased in a registered direct offering at a price of $6.50, for an aggregate purchase price of $13,000,000 pursuant to a securities purchase agreement dated September 12, 2024. The Warrants are exercisable on or after March 16, 2025 and will terminate on March 16, 2030 unless such termination is accelerated pursuant to the terms of the Warrants (the \"Termination Date\"), provided, however, in the event that the Warrant is held by Insiders and the Termination Date is during a period that such Insiders are subject to a blackout with respect to trading in the Company's common stock, such Insiders will have an additional 60 days from the termination of the blackout to exercise the Warrant. The exercise price the Warrants is $6.40 per share subject to adjustment as provided in the Warrant."}],"balance_after":15380,"derivative":{"exercise_price":6.4,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":15380},"source":{"system":"sec-edgar","filing":"0001213900-24-079121","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390024079121/ownership.xml","form_type":"4"}},{"id":1406319,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-17T00:48:44.000Z","date":"2024-09-12","kind":"purchase","planned":false,"acquired":true,"shares":15380,"price":6.375,"value":98047.5,"ownership":{"direct":true},"balance_after":1554106,"source":{"system":"sec-edgar","filing":"0001213900-24-079121","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390024079121/ownership.xml","form_type":"4"}},{"id":1481650,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Option (right to buy)","published_at":"2024-06-12T20:30:48.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":37882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the INmune Bio Inc. 2021 Stock Incentive Plan. The option is 100% vested and exercisable as of the grant date."}],"balance_after":37882,"derivative":{"exercise_price":8.72,"expiration_date":"2034-06-09","underlying":"Common Stock","underlying_shares":37882},"source":{"system":"sec-edgar","filing":"0001213900-24-052113","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390024052113/ownership.xml","form_type":"4"}},{"id":1513760,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Option (right to buy)","published_at":"2024-05-16T20:10:52.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the 2021 Stock Incentive Plan. One fourth (1/4) of the option will vest 12 months from the grant date and thereafter the remaining unvested option will become vested and exercisable on a monthly basis over three (3) years (1/36 per month) until the option is 100% vested which shall occur on the four-year anniversary of the grant date."}],"balance_after":160000,"derivative":{"exercise_price":9.92,"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001213900-24-044315","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390024044315/ownership.xml","form_type":"4"}},{"id":1535991,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock Warrants (right to buy)","published_at":"2024-04-24T18:08:45.000Z","date":"2024-04-19","kind":"purchase","planned":false,"acquired":true,"shares":18028,"price":0.125,"value":2253.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The common shares and warrants reported on this Form 4 were purchased in a registered direct offering at a price of $8.445, for an aggregate purchase price of $152,246.46 pursuant to a securities purchase agreement dated April 19, 2024. The warrants are exercisable immediately upon issuance until the earlier of (i) the two year anniversary of the initial exercise date or (ii) thirty trading days following the reporting of the top line data (EMACC) in the Phase 2 Alzheimer's program of XPro1595, (the \"Termination Date\") but not thereafter, provided however, in the event that the Warrant is held by directors, officers or other affiliates of the Company and the Termination Date is during a period that such officers, directors or affiliates are subject to a blackout with respect to trading in the Company's common stock, such officers, directors or affiliates will have an additional 60 days from the termination of the blackout date to exercise the Warrant."}],"balance_after":18028,"derivative":{"exercise_price":9.152,"exercise_date":"2024-04-24","underlying":"Common Stock","underlying_shares":18028},"source":{"system":"sec-edgar","filing":"0001213900-24-035722","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390024035722/ownership.xml","form_type":"4/A","original_submission_date":"2024-04-23"}},{"id":1535990,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-04-24T18:08:45.000Z","date":"2024-04-19","kind":"purchase","planned":false,"acquired":true,"shares":18028,"price":8.32,"value":149992.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common shares and warrants reported on this Form 4 were purchased in a registered direct offering at a price of $8.445, for an aggregate purchase price of $152,246.46 pursuant to a securities purchase agreement dated April 19, 2024. The warrants are exercisable immediately upon issuance until the earlier of (i) the two year anniversary of the initial exercise date or (ii) thirty trading days following the reporting of the top line data (EMACC) in the Phase 2 Alzheimer's program of XPro1595, (the \"Termination Date\") but not thereafter, provided however, in the event that the Warrant is held by directors, officers or other affiliates of the Company and the Termination Date is during a period that such officers, directors or affiliates are subject to a blackout with respect to trading in the Company's common stock, such officers, directors or affiliates will have an additional 60 days from the termination of the blackout date to exercise the Warrant."}],"balance_after":1538726,"source":{"system":"sec-edgar","filing":"0001213900-24-035722","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390024035722/ownership.xml","form_type":"4/A","original_submission_date":"2024-04-23"}},{"id":1536684,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock Warrants (right to buy)","published_at":"2024-04-23T21:55:21.000Z","date":"2024-04-19","kind":"grant","planned":false,"acquired":true,"shares":18028,"price":0.125,"value":2253.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The common shares and warrants reported on this Form 4 were purchased in a registered direct offering at a price of $8.445, for an aggregate purchase price of $152,246.46 pursuant to a securities purchase agreement dated April 19, 2024. The warrants are exercisable immediately upon issuance until the earlier of (i) the two year anniversary of the initial exercise date or (ii) thirty trading days following the reporting of the top line data (EMACC) in the Phase 2 Alzheimer's program of XPro1595, (the \"Termination Date\") but not thereafter, provided however, in the event that the Warrant is held by directors, officers or other affiliates of the Company and the Termination Date is during a period that such officers, directors or affiliates are subject to a blackout with respect to trading in the Company's common stock, such officers, directors or affiliates will have an additional 60 days from the termination of the blackout date to exercise the Warrant."}],"balance_after":18028,"derivative":{"exercise_price":9.152,"exercise_date":"2024-04-24","underlying":"Common Stock","underlying_shares":18028},"source":{"system":"sec-edgar","filing":"0001213900-24-035474","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390024035474/ownership.xml","form_type":"4"}},{"id":1536683,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-04-23T21:55:21.000Z","date":"2024-04-19","kind":"grant","planned":false,"acquired":true,"shares":18028,"price":8.32,"value":149992.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common shares and warrants reported on this Form 4 were purchased in a registered direct offering at a price of $8.445, for an aggregate purchase price of $152,246.46 pursuant to a securities purchase agreement dated April 19, 2024. The warrants are exercisable immediately upon issuance until the earlier of (i) the two year anniversary of the initial exercise date or (ii) thirty trading days following the reporting of the top line data (EMACC) in the Phase 2 Alzheimer's program of XPro1595, (the \"Termination Date\") but not thereafter, provided however, in the event that the Warrant is held by directors, officers or other affiliates of the Company and the Termination Date is during a period that such officers, directors or affiliates are subject to a blackout with respect to trading in the Company's common stock, such officers, directors or affiliates will have an additional 60 days from the termination of the blackout date to exercise the Warrant."}],"balance_after":1538726,"source":{"system":"sec-edgar","filing":"0001213900-24-035474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390024035474/ownership.xml","form_type":"4"}},{"id":2002767,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Option (right to buy)","published_at":"2023-02-21T21:09:44.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date."}],"balance_after":160000,"derivative":{"exercise_price":9.74,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001213900-23-013286","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390023013286/ownership.xml","form_type":"4"}},{"id":2250816,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-31T10:10:09.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":6300,"price":6.41,"value":40383.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the average purchase price at a range of between $6.37 and $6.43 per share."}],"balance_after":1520698,"source":{"system":"sec-edgar","filing":"0001213900-22-030210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390022030210/ownership.xml","form_type":"4"}},{"id":2319694,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Option (right to buy)","published_at":"2022-03-23T20:33:16.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date."}],"balance_after":130000,"derivative":{"exercise_price":7.92,"expiration_date":"2032-03-20","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001213900-22-014507","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390022014507/ownership.xml","form_type":"4"}},{"id":2319693,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-23T20:33:16.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":23724,"price":8.43,"value":199993.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price of the common stock being reported is the closing price per share immediately preceding the entering into of the binding agreement to issue the securities . These shares were purchased by the Reporting Person directly from Issuer."}],"balance_after":1514398,"source":{"system":"sec-edgar","filing":"0001213900-22-014507","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390022014507/ownership.xml","form_type":"4"}},{"id":2524182,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-04T20:00:37.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":3626,"price":20,"value":72520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1490674,"source":{"system":"sec-edgar","filing":"0001213900-21-056737","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390021056737/ownership.xml","form_type":"4"}},{"id":2531558,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-29T20:03:56.000Z","date":"2021-10-27","kind":"sale","acquired":false,"shares":6517,"price":20,"value":130340.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1494300,"source":{"system":"sec-edgar","filing":"0001213900-21-055422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390021055422/ownership.xml","form_type":"4"}},{"id":2534322,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-26T20:31:29.000Z","date":"2021-10-22","kind":"sale","acquired":false,"shares":23616,"price":20,"value":472320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1500817,"source":{"system":"sec-edgar","filing":"0001213900-21-054644","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390021054644/ownership.xml","form_type":"4"}},{"id":2587623,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-27T20:42:16.000Z","date":"2021-08-25","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were exercised in a cash transaction by the Reporting Person under Rule 16(b)(3). The options were granted to the Reporting Person under the Company's 2019 Stock Incentive Plan."}],"balance_after":270000,"derivative":{"exercise_price":3.91,"expiration_date":"2029-11-24","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001213900-21-045373","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390021045373/ownership.xml","form_type":"4"}},{"id":2587622,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-27T20:42:16.000Z","date":"2021-08-25","kind":"exercise","acquired":true,"shares":30000,"price":3.91,"value":117300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were exercised in a cash transaction by the Reporting Person under Rule 16(b)(3). The options were granted to the Reporting Person under the Company's 2019 Stock Incentive Plan."}],"balance_after":1524433,"source":{"system":"sec-edgar","filing":"0001213900-21-045373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390021045373/ownership.xml","form_type":"4"}},{"id":2636708,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-09T20:06:16.000Z","date":"2021-07-08","kind":"sale","acquired":false,"shares":24351,"price":20.08,"value":488968.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.21, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above."}],"balance_after":1510933,"source":{"system":"sec-edgar","filing":"0001213900-21-036352","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390021036352/ownership.xml","form_type":"4"}},{"id":2636707,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-09T20:06:16.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":5649,"price":20.018,"value":113081.682,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.04, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above."}],"balance_after":1535284,"source":{"system":"sec-edgar","filing":"0001213900-21-036352","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390021036352/ownership.xml","form_type":"4"}},{"id":2655475,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Option","published_at":"2021-06-24T22:00:53.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":70663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Option represents a right to receive one share of common stock of INmune Bio, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options granted pursuant to 2021 Stock Incentive Plan. Twenty-five percent of the Option will vest 12 months from the date of grant and thereafter the remaining unvested Option will become vested and exercisable pro rata on a monthly basis over three (3) years (1/36 per month) until the Option is 100% vested which shall occur on the four-year anniversary of the date of grant."}],"balance_after":70663,"derivative":{"exercise_price":17.49,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":70663},"source":{"system":"sec-edgar","filing":"0001213900-21-034018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390021034018/ownership.xml","form_type":"4"}},{"id":2900185,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Option","published_at":"2021-01-21T21:34:18.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":59337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Option represents a right to receive one share of common stock of INmune Bio, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options granted pursuant to 2019 Stock Incentive Plan Twenty-five percent of the Option will vest 12 months from the date of grant and thereafter the remaining unvested Option will become vested and exercisable pro rata on a monthly basis over three (3) years (1/36 per month) until the Option is 100% vested which shall occur on the four-year anniversary of the date of grant."}],"balance_after":59337,"derivative":{"exercise_price":24.82,"expiration_date":"2031-01-18","underlying":"Common Stock","underlying_shares":59337},"source":{"system":"sec-edgar","filing":"0001213900-21-003483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390021003483/ownership.xml","form_type":"4"}},{"id":3357022,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Option","published_at":"2019-11-27T21:41:57.000Z","date":"2019-11-25","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Option represents a right to receive one share of common stock of INmune Bio, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests pro rata on a monthly basis over three years (1/36) such that the Option will be fully vested three years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Vests pro rata on a monthly basis over three years (1/36) such that the Option will be fully vested three years from the date of grant."}],"balance_after":700000,"derivative":{"exercise_price":3.91,"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-19-024971","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019024971/ownership.xml","form_type":"4"}},{"id":3431701,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:33:04.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":1000,"price":6.0308,"value":6030.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions."}],"balance_after":1540933,"source":{"system":"sec-edgar","filing":"0001213900-19-016453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/ownership.xml","form_type":"4"}},{"id":3431700,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:33:04.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":100,"price":5.9239,"value":592.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions."}],"balance_after":1539933,"source":{"system":"sec-edgar","filing":"0001213900-19-016453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/ownership.xml","form_type":"4"}},{"id":3431699,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:33:04.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":100,"price":5.96,"value":596.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions."}],"balance_after":1539833,"source":{"system":"sec-edgar","filing":"0001213900-19-016453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/ownership.xml","form_type":"4"}},{"id":3431698,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:33:04.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":100,"price":5.96,"value":596.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions."}],"balance_after":1539733,"source":{"system":"sec-edgar","filing":"0001213900-19-016453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/ownership.xml","form_type":"4"}},{"id":3431697,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:33:04.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":100,"price":5.96,"value":596.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions."}],"balance_after":1539633,"source":{"system":"sec-edgar","filing":"0001213900-19-016453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/ownership.xml","form_type":"4"}},{"id":3431696,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:33:04.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":100,"price":5.96,"value":596.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions."}],"balance_after":1539533,"source":{"system":"sec-edgar","filing":"0001213900-19-016453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/ownership.xml","form_type":"4"}},{"id":3431695,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:33:04.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":100,"price":5.96,"value":596.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions."}],"balance_after":1539433,"source":{"system":"sec-edgar","filing":"0001213900-19-016453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/ownership.xml","form_type":"4"}},{"id":3431694,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:33:04.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":100,"price":5.96,"value":596.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions."}],"balance_after":1539333,"source":{"system":"sec-edgar","filing":"0001213900-19-016453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/ownership.xml","form_type":"4"}},{"id":3431693,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:33:04.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":100,"price":5.96,"value":596.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions."}],"balance_after":1539233,"source":{"system":"sec-edgar","filing":"0001213900-19-016453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/ownership.xml","form_type":"4"}},{"id":3431692,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:33:04.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":100,"price":5.96,"value":596.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions."}],"balance_after":1539133,"source":{"system":"sec-edgar","filing":"0001213900-19-016453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/ownership.xml","form_type":"4"}},{"id":3431691,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:33:04.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":100,"price":5.96,"value":596.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions."}],"balance_after":1539033,"source":{"system":"sec-edgar","filing":"0001213900-19-016453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/ownership.xml","form_type":"4"}},{"id":3440713,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-12T21:34:28.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":1000,"price":6.9095,"value":6909.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 9, 2019 in two open market transactions."}],"balance_after":1538933,"source":{"system":"sec-edgar","filing":"0001213900-19-015380","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019015380/ownership.xml","form_type":"4"}},{"id":3440712,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-12T21:34:28.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":900,"price":7.1431,"value":6428.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 9, 2019 in two open market transactions."}],"balance_after":1537933,"source":{"system":"sec-edgar","filing":"0001213900-19-015380","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019015380/ownership.xml","form_type":"4"}},{"id":3440711,"issuer":{"id":7094,"kind":"organization","name":"Inmune Bio, Inc.","symbol":"INMB"},"owners":[{"id":85299,"kind":"person","name":"Tesi Raymond Joseph","position":1,"cik":"0001767280","reported_name":"Tesi Raymond Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-12T21:34:28.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":100,"price":7.2,"value":720.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 9, 2019 in two open market transactions."}],"balance_after":1537033,"source":{"system":"sec-edgar","filing":"0001213900-19-015380","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390019015380/ownership.xml","form_type":"4"}}]}